Edyta A. Szurek

Edyta A. Szurek

Auto-generated profile, based on publicly available information

Edyta A. Szurek

Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
MKMichal Kuczma
Michal Kuczma
ESEdyta A. Szurek
Edyta A. Szurek
ACAnna Cebula
Anna Cebula
Chassaing BenoitChassaing Benoit
Chassaing Benoit
YJYu-Jin Jung
Yu-Jin Jung
LILeszek Ignatowicz
Leszek Ignatowicz
The gut microbiome is the largest source of intrinsic non–self-antigens that are continuously sensed by the immune system but typically do not elicit lymphocyte responses. CD4+ T cells are critical to sustain uninterrupted tolerance to microbial antigens and to prevent intestinal inflammation. However, clinical interventions targeting commensal bacteria–specific CD4+ T cells are rare, because only a very limited number of commensal-derived epitopes have been identified. Here, we used a new approach to study epitopes and identify T cell receptors expressed by CD4+Foxp3+ (Treg) cells specific for commensal-derived antigens. Using this approach, we found that antigens from Akkermansia muciniphila reprogram naïve CD4+ T cells to the Treg lineage, expand preexisting microbe specific Tregs, and limit wasting disease in the CD4+ T cell transfer model of colitis. These data suggest that the administration of specific commensal epitopes may help to widen the repertoire of specific Tregs that control intestinal inflammation.

21 December 2018 in Cryobiology
Verified
Journal Article
Closed access
ESEdyta A. Szurek
Edyta A. Szurek
NDNerlyne Dhariwal
Nerlyne Dhariwal
AEAli Eroǧlu
Ali Eroǧlu